Literature DB >> 33512527

Environmental Contamination of Contact Precaution and Non-Contact Precaution Patient Rooms in Six Acute Care Facilities.

Windy D Tanner1,2, Molly K Leecaster1,2, Yue Zhang1, Kristina M Stratford1,2, Jeanmarie Mayer1,2, Lindsay D Visnovsky1,2, Heba Alhmidi3, Jennifer L Cadnum3, Annette L Jencson3, Sreelatha Koganti3, Christina P Bennett3, Curtis J Donskey4, Judith Noble-Wang5, Sujan C Reddy5, Laura J Rose5, Lauren Watson6, Emma Ide6, Tyler Wipperfurth6, Nasia Safdar6,7, Maria Arasim8, Colleen Macke8, Patti Roman8, Sarah L Krein8,9, Catherine Loc-Carrillo1,2, Matthew H Samore1,2.   

Abstract

BACKGROUND: Environmental contamination is an important source of hospital multidrug-resistant organism (MDRO) transmission. Factors such as patient MDRO contact precautions (CP) status, patient proximity to surfaces, and unit type likely influence MDRO contamination and bacterial bioburden levels on patient room surfaces. Identifying factors associated with environmental contamination in patient rooms and on shared unit surfaces could help identify important environmental MDRO transmission routes.
METHODS: Surfaces were sampled from MDRO CP and non-CP rooms, nursing stations, and mobile equipment in acute care, intensive care, and transplant units within 6 acute care hospitals using a convenience sampling approach blinded to cleaning events. Precaution rooms had patients with clinical or surveillance tests positive for methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, carbapenem-resistant Enterobacteriaceae or Acinetobacter within the previous 6 months, or Clostridioides difficile toxin within the past 30 days. Rooms not meeting this definition were considered non-CP rooms. Samples were cultured for the above MDROs and total bioburden.
RESULTS: Overall, an estimated 13% of rooms were contaminated with at least 1 MDRO. MDROs were detected more frequently in CP rooms (32% of 209 room-sample events) than non-CP rooms (12% of 234 room-sample events). Surface bioburden did not differ significantly between CP and non-CP rooms or MDRO-positive and MDRO-negative rooms.
CONCLUSIONS: CP room surfaces are contaminated more frequently than non-CP room surfaces; however, contamination of non-CP room surfaces is not uncommon and may be an important reservoir for ongoing MDRO transmission. MDRO contamination of non-CP rooms may indicate asymptomatic patient MDRO carriage, inadequate terminal cleaning, or cross-contamination of room surfaces via healthcare personnel hands.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  contact precautions; environmental surfaces; healthcare environment; healthcare-associated infections; multidrug resistance

Mesh:

Year:  2021        PMID: 33512527      PMCID: PMC8785946          DOI: 10.1093/cid/ciaa1602

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  34 in total

1.  Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications.

Authors:  J M Boyce; G Potter-Bynoe; C Chenevert; T King
Journal:  Infect Control Hosp Epidemiol       Date:  1997-09       Impact factor: 3.254

2.  Prevalence of the Clostridium difficile BI/NAP1/027 strain across the United States Veterans Health Administration.

Authors:  S E Giancola; R J Williams; C A Gentry
Journal:  Clin Microbiol Infect       Date:  2017-11-22       Impact factor: 8.067

3.  Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit.

Authors:  S Nseir; C Blazejewski; R Lubret; F Wallet; R Courcol; A Durocher
Journal:  Clin Microbiol Infect       Date:  2010-12-13       Impact factor: 8.067

4.  National validation study of a cellulose sponge wipe-processing method for use after sampling Bacillus anthracis spores from surfaces.

Authors:  Laura J Rose; Lisa Hodges; Heather O'Connell; Judith Noble-Wang
Journal:  Appl Environ Microbiol       Date:  2011-09-30       Impact factor: 4.792

5.  ESBL-producing Gram-negative organisms in the healthcare environment as a source of genetic material for resistance in human infections.

Authors:  M Muzslay; G Moore; N Alhussaini; A P R Wilson
Journal:  J Hosp Infect       Date:  2016-09-17       Impact factor: 3.926

6.  Contamination of hands with methicillin-resistant Staphylococcus aureus after contact with environmental surfaces and after contact with the skin of colonized patients.

Authors:  Usha Stiefel; Jennifer L Cadnum; Brittany C Eckstein; Dubert M Guerrero; Mary Ann Tima; Curtis J Donskey
Journal:  Infect Control Hosp Epidemiol       Date:  2011-02       Impact factor: 3.254

7.  Widespread environmental contamination associated with patients with diarrhea and methicillin-resistant Staphylococcus aureus colonization of the gastrointestinal tract.

Authors:  John M Boyce; Nancy L Havill; Jonathan A Otter; Nicholas M T Adams
Journal:  Infect Control Hosp Epidemiol       Date:  2007-08-03       Impact factor: 3.254

8.  Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit.

Authors:  José A Martínez; Robin Ruthazer; Karen Hansjosten; Laurie Barefoot; David R Snydman
Journal:  Arch Intern Med       Date:  2003-09-08

9.  Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistant enterococcus or the colonized patients' environment.

Authors:  Mary K Hayden; Donald W Blom; Elizabeth A Lyle; Charity G Moore; Robert A Weinstein
Journal:  Infect Control Hosp Epidemiol       Date:  2008-02       Impact factor: 3.254

10.  Burn injury outcomes in patients with pre-existing diabetic mellitus: Risk of hospital-acquired infections and inpatient mortality.

Authors:  Laquanda Knowlin; Paula D Strassle; Felicia N Williams; Richard Thompson; Samuel Jones; David J Weber; David van Duin; Bruce A Cairns; Anthony Charles
Journal:  Burns       Date:  2017-10-10       Impact factor: 2.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.